Product Name: Moxifloxacin HCl
Structure:

CAS NO: 186826-86-8
Specification: EP; USP; BP
Documents: MSDS；Tech Package
Usage: A fourth-generation synthetic fluoroquinolone antibacterial agent，treat a number of infections,including: respiratory tract infections, cellulitis, anthrax,endocarditis, meningitis,and tuberculosis.
Supplementary information: Developed by Bayer AG，marketed worldwide (as the hydrochloride) under the brand names Avelox, Avalox, and Avelon for oral treatment. In most countries, the drug is also available in parenteral form for intravenous infusion